Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.
BRAF and MEK inhibitors
BRAFV600E
RNAseq
combination of encorafenib and binimetinib
drug holiday
drug resistance
malignant melanoma
proteome array
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
received:
26
10
2021
revised:
24
11
2021
accepted:
29
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
Combination treatment using BRAF/MEK inhibitors is a promising therapy for patients with advanced
Identifiants
pubmed: 34885166
pii: cancers13236058
doi: 10.3390/cancers13236058
pmc: PMC8656772
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National National Research Development and Innovation Fund Hungary
ID : K-135752
Organisme : European Regional Development Fund
ID : GINOP-2.3.2-15-2016-00005
Organisme : Hungarian Academy of Sciences
ID : TK2016-7
Organisme : New National Excellence Program of the Ministry for Innovation and Technology from the Source of National research, Development and Innovation Fund
ID : UNKP-21-4-II-DE-361 and UNKP-21-4-II-DE-363
Références
Theranostics. 2019 Sep 21;9(23):6840-6855
pubmed: 31660072
Br J Cancer. 2017 Dec 5;117(12):1828-1836
pubmed: 29065106
Cureus. 2015 Dec 16;7(12):e410
pubmed: 26824010
Front Oncol. 2019 Aug 06;9:739
pubmed: 31448238
Int J Oncol. 2020 Aug;57(2):409-432
pubmed: 32468071
Front Oncol. 2018 Jun 12;8:202
pubmed: 29946532
Curr Opin Oncol. 2021 Mar 1;33(2):127-132
pubmed: 33315631
Nat Rev Cancer. 2017 Oct 25;17(11):634-635
pubmed: 29068004
J Clin Oncol. 2018 Mar 1;36(7):667-673
pubmed: 28991513
Expert Rev Clin Pharmacol. 2019 Mar;12(3):259-266
pubmed: 30652516
Pigment Cell Melanoma Res. 2012 Sep;25(5):592-601
pubmed: 22672152
Cancers (Basel). 2020 Sep 29;12(10):
pubmed: 33003483
Cells. 2020 Apr 16;9(4):
pubmed: 32316277
Front Mol Biosci. 2020 Jul 14;7:154
pubmed: 32760738
J Transl Med. 2016 Jul 28;14(1):225
pubmed: 27465405
Hematol Oncol Clin North Am. 2021 Feb;35(1):111-128
pubmed: 33759769
Data Brief. 2020 Apr 22;30:105610
pubmed: 32382617
Melanoma Res. 2019 Aug;29(4):390-400
pubmed: 30741840
Microbiome. 2020 Mar 17;8(1):39
pubmed: 32178738
Br J Cancer. 2011 Jan 4;104(1):155-65
pubmed: 21081927
J Dermatol. 2020 Oct;47(10):1141-1148
pubmed: 32734632
Drug Resist Updat. 2007 Jun;10(3):101-8
pubmed: 17544840
J Transl Med. 2012 Jul 09;10:85
pubmed: 22554099
Cancer Cell Int. 2020 Jun 24;20:267
pubmed: 32595416
Front Immunol. 2018 Jul 16;9:1533
pubmed: 30061880
Cancer Discov. 2018 Jan;8(1):74-93
pubmed: 28923912
Drug Discov Today. 2015 May;20(5):578-87
pubmed: 25433305
Am J Pathol. 2008 Dec;173(6):1839-52
pubmed: 18988806
Clin Cancer Res. 2017 Sep 15;23(18):5339-5348
pubmed: 28611198
Cell Cycle. 2019 Nov;18(21):2860-2875
pubmed: 31599708
PLoS One. 2010 May 18;5(5):e10696
pubmed: 20502531
Br J Cancer. 2017 Apr 11;116(8):1065-1076
pubmed: 28301874
Am J Clin Dermatol. 2021 May;22(3):301-314
pubmed: 33765322
Nature. 2017 Oct 12;550(7675):270-274
pubmed: 28976960
Int J Mol Sci. 2019 Dec 23;21(1):
pubmed: 31877948
Cell. 2004 Mar 19;116(6):855-67
pubmed: 15035987
Genes (Basel). 2019 May 29;10(6):
pubmed: 31146489
BMC Cancer. 2010 Mar 01;10:73
pubmed: 20187983
Target Oncol. 2016 Aug;11(4):557-63
pubmed: 26857260
Lancet Oncol. 2018 May;19(5):603-615
pubmed: 29573941
Int J Mol Sci. 2020 Jun 27;21(13):
pubmed: 32605090
Neoplasia. 2009 Sep;11(9):901-9
pubmed: 19724684
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Science. 2009 Dec 18;326(5960):1619
pubmed: 20019269
Nature. 2013 Feb 14;494(7436):251-5
pubmed: 23302800
Nat Commun. 2018 Aug 9;9(1):3192
pubmed: 30093685
Int J Mol Sci. 2019 Sep 11;20(18):
pubmed: 31514305
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352
pubmed: 32300252
Biomol Ther (Seoul). 2019 May 1;27(3):302-310
pubmed: 30293252
Nat Med. 2020 Oct;26(10):1564-1568
pubmed: 33020646
Mol Cancer. 2018 Feb 17;17(1):59
pubmed: 29454361
J Clin Invest. 2014 Jul;124(7):2877-90
pubmed: 24865425
Nat Rev Cancer. 2018 Jul;18(7):452-464
pubmed: 29643473
Hematology. 2015 Aug;20(7):384-91
pubmed: 26218201
Cancers (Basel). 2021 Jan 09;13(2):
pubmed: 33435389
Cancers (Basel). 2020 Feb 19;12(2):
pubmed: 32092958
Melanoma Res. 2016 Apr;26(2):100-7
pubmed: 26656572